(Q35547391)

8 August 2017

1 reference

title

Targeting tumor cells (English)

1 reference

8 August 2017

2

Albert Zlotnik

1 reference

8 August 2017

Pantea Houshmand

1

1 reference

8 August 2017

1 October 2003

1 reference

Current Opinion in Cell Biology

8 August 2017

1 reference

8 August 2017

15

1 reference

8 August 2017

5

1 reference

8 August 2017

640-644

1 reference

Protein engineering techniques for antibody humanization

8 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Human antibodies as next generation therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Antibody-based therapeutics in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

The genetics and genomics of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Gastrointestinal Stromal Tumors and Other Mesenchymal Lesions of the Gut

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Taking aim at Ewing's sarcoma: is KIT a target and will imatinib work?

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Practical management of patients with chronic myeloid leukemia receiving imatinib

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Expression profiling predicts outcome in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Dissemination and growth of cancer cells in metastatic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Involvement of chemokine receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Role of integrins in cell invasion and migration

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Matrix metalloproteinases in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

A molecular signature of metastasis in primary solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0955-0674%2803%2900106-6

7 January 2021

10.1016/S0955-0674(03)00106-6

Identifiers

DOI

1 reference

8 August 2017

1 reference

PubMed ID

14519400